As AquaBounty readies US rollout of GMO salmon, scientists hope for jumpstart of biotech animal research

ps geneeditinganimals featured

A genetically modified salmon will become the first GM food animal to go on sale in the US, according to its maker, AquaBounty, possibly launching an era of steaks and chops from creatures with modified DNA.

In the US, a number of genetically modified animals have been approved or cleared for sale. There’s the neon GloFish with added fluorescence, which you can find at a pet store. And there are a handful of goats, rabbits, and chickens engineered to manufacture drugs in their milk or eggs.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

But so far, only one genetically engineered animal has been approved in the US as food. That animal, an Atlantic salmon engineered to grow faster on fish farms, took 20 years to win a nod from regulators, and then got held up for four more years over a labeling dispute. AquaBounty predicted that it would be ready to sell salmon to distributors in the US by [Dec. 2020].

Related article:  Greenlighting of AquAdvantage salmon could 'pave the way' to disease resistant pigs and other GMO animals

ADVERTISEMENT

AquaBounty’s long (and expensive) trip to the marketplace has been discouraging. Who wants their product to be denounced as a frankenfish by environmental campaigners or be prominently labeled as “bioengineered”? Yet now that the fish has won approval, it may be a “wildly important” signal to others working on genetically engineered animals, says Jack Bobo, a former board member at the company. “All GMO research on animals basically stopped for 20 years,” he says. “There was no reason to do it until something got approved.”

Read the original post [behind paywall]

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend